CME Group (CME) Names Lynne Fitzpatrick as Next CEO, Succeeding Terry Duffy in March 2027

CME Group (CME) announced Lynne Fitzpatrick will succeed Terry Duffy as Chief Executive Officer, effective March 2027. Duffy, who currently serves as Chairman and CEO, will transition to Executive Chairman of the board. This leadership change marks a planned succession for the world's leading derivatives marketplace. Fitzpatrick currently holds the position of President at CME Group. Her appointment follows a comprehensive internal search process. The transition ensures continuity in leadership as the company navigates evolving global markets, maintaining its strategic direction.